Stock BIOSGN BIOSERGEN AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Biosergen AB

Equities

BIOSGN

SE0016013460

Market Closed - Nasdaq Stockholm
Other stock markets
 10:38:12 2024-04-23 am EDT 		5-day change 1st Jan Change
0.387 SEK +12.50% Intraday chart for Biosergen AB -14.76% -56.02%
Apr. 09 Biosergen to Issue New Units as Compensation Under Rights Issue MT
Mar. 27 Biosergen Raises SEK26.4 Million via Rights Issue MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Conversion of paid subscribed units and first day of trading with warrants of series TO3
AQ
Biosergen to Issue New Units as Compensation Under Rights Issue
MT
Biosergen resolves on a directed issue to underwriters in connection with the completed rights issue
AQ
Biosergen Raises SEK26.4 Million via Rights Issue
MT
Biosergen announces the outcome in the rights issue
AQ
BioStock Investor Pitch: Biosergen
AQ
Members of the board of directors and management subscribe in ongoing rights issue
AQ
Research update Biosergen: Rights issue to fund crucial step for lead project
AQ
BioStock: Rights issue to give Biosergen first in-human efficacy data
AQ
BioStock: Biosergen attacks invisible threat of fungal infections
AQ
Carlsquare Equity Research interview with Biosergen
AQ
Biosergen CEO to BioStock: "Positive data give us a strong value proposition"
AQ
Biosergen publishes prospectus due to rights issue of units
AQ
Bulletin from the extraordinary general meeting in Biosergen AB (publ)
AQ
Biosergen publishes interim report for fourth quarter 2023
AQ
Biosergen AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Norway's Biosergen Secures Indian Regulatory Approval for Clinical Trial of Fungal Infections Therapy
MT
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.
AQ
Biosergen AB Receives Regulatory Approval to Test Lead Candidate Bsg005 in Patients with Invasive Fungal Infection
CI
Mrkt BUZZ, Biosergen: Rights issue to fund the next clinical step
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOSGN Stock
  4. News Biosergen AB